Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse Clinical Outcomes.
Ladwig NR, Umetsu SE, Zaloudek C, Rabban J, Garg K.
Int J Gynecol Pathol. 2021 Mar 1;40(2):103-115. doi: 10.1097/PGP.0000000000000671.
PMID:32909971
[Incidence and mortality of corpus uteri cancer in China, 2015].
Ma JY, Zhou Y, Lin YT, Xiang ZS, Zheng RS, Zhang SW, Wang SM, Chen R, Wei WW, He J.
Zhonghua Zhong Liu Za Zhi. 2021 Jan 23;43(1):108-112. doi: 10.3760/cma.j.cn112152-20200423-00373.
PMID:33472322
Global incidence and mortality trends of corpus uteri cancer and associations with gross domestic product, human development index, lifestyle, and metabolic risk factors.
Huang J, Chan WC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE 3rd, Xu W, Zheng ZJ, Elcarte E, Withers M, Wong MCS; NCD Global Health Research Group, Association of Pacific Rim Universities.
Int J Gynaecol Obstet. 2023 Sep;162(3):998-1009. doi: 10.1002/ijgo.14780. Epub 2023 May 2.
Human LY6 gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma.
Rathbun LA, Magliocco AM, Bamezai AK.
Oncotarget. 2023 May 4;14:426-437. doi: 10.18632/oncotarget.28409.
PMID:37141412
Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends.
Azhetova Z, Khamidullina Z, Telmanova Z, Assylbek A, Bilyalova Z, Igissinova G, Orazova G, Kassenova D, Tarzhanova D, Kazbekova K, Idrissov K, Jakipbekova Z, Shuasheva Y, Dolanova G, Kuandykov Y, Mutagirov V, Kuandykov T, Igissinov N.
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):849-857. doi: 10.31557/APJCP.2023.24.3.849.
PMID:36974537
Epidemiology of Breast, Corpus Uteri, and Ovarian Cancers in Lebanon With Emphasis on Breast Cancer Incidence Trends and Risk Factors Compared to Regional and Global Rates.
Lakkis NA, Abdallah RM, Musharrafieh UM, Issa HG, Osman MH.
Cancer Control. 2024 Jan-Dec;31:10732748241236266. doi: 10.1177/10732748241236266.